CorVel (NASDAQ:CRVL – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday.
CorVel Stock Performance
Shares of NASDAQ:CRVL opened at $110.72 on Friday. The firm has a market capitalization of $5.69 billion, a PE ratio of 23.51 and a beta of 1.15. CorVel has a 52-week low of $74.63 and a 52-week high of $127.24. The firm has a fifty day moving average of $124.34 and a 200 day moving average of $107.88.
Insider Buying and Selling
In related news, EVP Mark E. Bertels sold 1,050 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $119.12, for a total value of $125,072.50. Following the sale, the executive vice president now owns 2,580 shares in the company, valued at $307,321. This represents a 28.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 47.57% of the stock is owned by insiders.
Institutional Inflows and Outflows
About CorVel
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Read More
- Five stocks we like better than CorVel
- How to Invest in Biotech Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- 3 Small Caps With Big Return Potential
- Nebius Group: The Rising Star in AI Infrastructure
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.